Akari Therapeutics PLC logo

Akari Therapeutics PLC - ADR

NEW
STU:CLA1 (USA)   ADR
€ 134.4 (0%) Aug 24
N/A
P/B:
0.74
Market Cap:
€ 262.08M ($ 305.57M)
Enterprise V:
€ 256.09M ($ 298.59M)
Volume:
0
Avg Vol (2M):
0
Trade In:

This is a preview!

Analysis and historical valuations for Apple Inc are shown here for you to look at this page's features.

Apple Inc Stock Intrinsic Values -